Jeff S. McDermott - Concepedia

Author

Jeff S. McDermott

Also Known As

J. McDermott, J.S. McDermott, Jeff McDermott, Jeff S McDermott, Jeff S. McDermott, Jeff S. Mcdermott, Jeffrey S McDermott, Jeffrey S. McDermott

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)Eli Lilly (United States)Abbott (United Kingdom)Abbott Fund Amgen (Germany)

About

Jeff S. McDermott is an author at Amgen (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	896
2	Natural Sciences	6	6	140
3	Health Sciences	1	1	15
4	Public Health	1	1	179
5	Social Sciences	1	1	66

Jeff S. McDermott

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
The Utility of hERG and Repolarization Assays in Evaluating Delayed Cardiac Repolarization: Influence of Multi-Channel Block Ruth L. Martin, Jeff S. McDermott, Heinz J. Salmen, Journal of Cardiovascular Pharmacology Cardiac MuscleHeart FailurePharmacotherapyBiomedical EngineeringExperimental Pharmacology	2004	179
<i>Chlamydomonas reinhardtii</i> Genome Project. A Guide to the Generation and Use of the cDNA Information Jeff Shrager, Charles R. Hauser, Chiung‐Wen Chang, PLANT PHYSIOLOGY GeneticsA GuideMolecular GeneticsGenomicsGene Recognition	2003	173
The Canine Purkinje Fiber: An In Vitro Model System for Acquired Long QT Syndrome and Drug-Induced Arrhythmogenesis Gary A. Gintant, James T. Limberis, Jeff S. McDermott, Journal of Cardiovascular Pharmacology Cardiac MuscleHeart FailurePathologyPharmacotherapyVitro Model System	2001	159
The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o Gilbert Diaz, Katina Daniell, Sandra Leitza, Journal of Pharmacological and Toxicological Methods Predictive Screening ToolMembrane PreparationsMedicinePhysiologyMechanism Of Action	2004	117
Tetrodotoxin-Resistant Sodium Channels in Sensory Neurons Generate Slow Resurgent Currents That Are Enhanced by Inflammatory Mediators Zhi‐Yong Tan, Andrew D. Piekarz, Birgit T. Priest, Journal of Neuroscience Synaptic TransmissionNeurotransmitterNeurotransmissionCellular NeurobiologyCellular Physiology	2014	66
Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain Bao-Xi Gao, Markus Hierl, Kristie Clarkin, Pain	2010	65
Identification of a Potent, State-Dependent Inhibitor of Nav1.7 with Oral Efficacy in the Formalin Model of Persistent Pain Howard Bregman, Loren Berry, John L. Buchanan, Journal of Medicinal Chemistry	2011	54
Transgenic Mouse Technology: Principles and Methods T. Rajendra Kumar, Melissa A. Larson, Huizhen Wang, Methods in molecular biology	2009	40
Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement Isaac E. Marx, Thomas A. Dineen, Jessica Able, ACS Medicinal Chemistry Letters	2016	37
Block of hERG channel by ziprasidone: Biophysical properties and molecular determinants Zhi Su, Jun Chen, Ruth L. Martin, Biochemical Pharmacology Biophysical ModelingNatural SciencesExperimental BiophysicsMolecular DeterminantsHerg Channel	2005	35

Page 1